Bvf Partners L P Olema Pharmaceuticals, Inc. (OLMA) insider trading activity

OLMA Quotes by TradingView

Bvf Partners L P is Director of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 347,970 shares of OLMA, which is worth approximately $2.21 Million. The most recent transaction as insider was on Jan 10, 2025, when has been sold 420,000 shares (Common Stock, $0.0001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 348K
33.61% 3M change
33.61% 12M change
Total Value Held $2.21 Million

BVF PARTNERS L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2025
SELL
Sale (or disposition) back to the issuer
-
420,000 Reduced 54.69%
347,970 Common Stock, $0.0001 ...
Dec 04 2024
SELL
Sale (or disposition) back to the issuer
-
3,369,704 Reduced 90.09%
370,710 Common Stock, $0.0001 ...
Sep 12 2023
BUY
Open market or private purchase
$14,818,370 $9.84 p/Share
1,505,932 Added 74.18%
524,151 Common Stock, $0.0001 ...
Jun 10 2022
BUY
Open market or private purchase
$806,000 $4.03 p/Share
200,000 Added 6.44%
2,906,659 Common Stock, $0.0001 ...
Nov 30 2021
BUY
Open market or private purchase
$6,945,549 $9.39 p/Share
739,675 Added 61.08%
471,350 Common Stock, $0.0001 ...
Nov 19 2020
BUY
Open market or private purchase
$21,571,346 $19.0 p/Share
1,135,334 Added 72.25%
436,082 Common Stock, $0.0001 ...
Nov 19 2020
BUY
Conversion of derivative security
-
5,216,676 Added 93.53%
361,091 Common Stock, $0.0001 ...

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CNCE
CONCERT PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CTIC
CTI BIOPHARMA CORP Healthcare
Director
XENE
Xenon Pharmaceuticals Inc. Healthcare
> 10% Shareholder
ARQL
ARQULE INC
> 10% Shareholder
SNDX
Syndax Pharmaceuticals Inc Healthcare
> 10% Shareholder
XOMA
XOMA Corp Healthcare
> 10% Shareholder
IMDZ
IMMUNE DESIGN CORP.
> 10% Shareholder
PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
GLYC
GLYCOMIMETICS INC Healthcare
> 10% Shareholder
FPRX
FIVE PRIME THERAPEUTICS, INC.
CALA
Calithera Biosciences, Inc. Healthcare
> 10% Shareholder
CYTK
CYTOKINETICS INC Healthcare
MRUS
Merus N.V. Healthcare
> 10% Shareholder
IDYA
IDEAYA Biosciences, Inc. Healthcare
PRNB
Principia Biopharma Inc.
> 10% Shareholder
KYMR
Kymera Therapeutics, Inc. Healthcare
Director
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
RAIN
Rain Therapeutics Inc. Healthcare
Director
RPTX
Repare Therapeutics Inc. Healthcare
> 10% Shareholder
CGEM
Cullinan Oncology, Inc. Healthcare
> 10% Shareholder
THRD
Third Harmonic Bio, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
> 10% Shareholder
MLTX
MoonLake Immunotherapeutics Healthcare
Director
PNT
POINT Biopharma Global Inc. Healthcare
FDMT
4D Molecular Therapeutics, Inc. Healthcare
BPL

Bvf Partners L P

Director
San Francisco, CA

Track Institutional and Insider Activities on OLMA

Follow Olema Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

News

Receive news related to Olema Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OLMA